HALIFAX, Nova Scotia, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces a financial package of over $5.23 million to support the Company’s FY2022 corporate strategy by its largest shareholder and related parties. As part of the deal, MedMira receives a cash injection of $1.67 million and a reduction of $3.56 million of the Company’s current liabilities in exchange for equity.
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.